Solana Influenza A+B Assay Kit

BY Quidel SKU QLCNM300

Rapid method of isothermal nucleic acid amplification that does not require thermal cycler
Easy-to-use format, just add processed sample to rehydrate
Eliminates the need for dedicated molecular space and costly capital equipment, allowing for testing in smaller labs
Requires minimal training
No freezer needed, 2˚C to 8˚C storage
No ice or cooling block required

$1,830.77

Description
Specifications
What's Included
Manuals & Documents
Warning

Description

The Solana Influenza A+B Assay is a rapid qualitative in vitro diagnostic test for the detection and differentiation of influenza A and influenza B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.

The Solana Influenza A+B Assay amplifies and detects viral RNA present in transport media containing nasopharyngeal or nasal swab specimens obtained from symptomatic patients.

Features

Rapid method of isothermal nucleic acid amplification that does not require thermal cycler
Easy-to-use format, just add processed sample to rehydrate
Eliminates the need for dedicated molecular space and costly capital equipment, allowing for testing in smaller labs
Requires minimal training
No freezer needed, 2˚C to 8˚C storage
No ice or cooling block required

Sold by

Solana Influenza A+B Assay Kit [48 test/kit]

California Prop 65

WARNING: This product can expose you to chemicals including arsenic, which is known to the State of California to cause cancer. For more information, visit Proposition 65

Specifications

Sample type	Nasal swabs and nasopharyngeal swabs in transport media* obtained from patients symptomatic of respiratory infection *BD/Copan VTM, Remel M4, Remel M4RT, Remel M5, Remel M6, or Copen eSwab
Time to results	Approximately 45 minutes
Reagent storage conditions	Lysis and Reaction Tubes; 2˚C to 8˚C
Controls storage conditions	2°C to 8°C
Sample preparation storage conditions	Specimens should be collected, transported, stored, and processed according to CLSI M41-A. Specimens should be stored at 2°C to 8°C until tested. Specimens collected in BD UTM, Remel M4, M4RT, M5, and M6 (3 mL) are stable at 2°C to 8°C for up to 9 days
Clinical Sensitivity (culture)	Influenza A: 98.6% (95% CI 96.8% to 99.4%) Influenza B: 100% (95% CI 95.7% to 100%)
Clinical Specificity (culture)	Influenza A: 95.1% (95% CI 93.7% to 96.3%) Influenza B: 99.3% (95% CI 98.7% to 99.6%)
Clinical Sensitivity (PCR)	Influenza A: 97.2% (95% CI 95.0% to 98.4%) Influenza B: 100.0% (95% CI 95.4% to 100%)
Clinical Specificity (PCR)	Influenza A: 96.7% (95% CI 95.4% to 97.7%) Influenza B: 98.9% (95% CI 98.2% to 99.4%)
LOD (Influenza A)	A/Taiwan/42/06: 7.5x102 TCID50/mL A/California/07/2009: 4.7x102 TCID50/mL A/Texas/50/2012: 6.3x100 TCID50/mL
LOD (Influenza B)	B/Brisbane/60/08: 8.5x101 TCID50/mL B/Massachusetts/2/2012: 3.3x101 TCID50/mL